Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/50097
DC FieldValueLanguage
dc.contributor.authorNaranjo, Antonio
dc.contributor.authorCáceres, Laura
dc.contributor.authorHernández-Beriaín, José Ángel
dc.contributor.authorFrancisco, Félix
dc.contributor.authorOjeda, Soledad
dc.contributor.authorTalaverano, Sigrid
dc.contributor.authorNóvoa-Medina, Javier
dc.contributor.authorMartín, José Adán
dc.contributor.authorDelgado, Esmeralda
dc.contributor.authorTrujillo, Elisa
dc.contributor.authorÁlvarez, Fátima
dc.contributor.authorMagdalena, Laura
dc.contributor.authorRodríguez-Lozano, Carlos
dc.date.accessioned2018-11-24T13:16:27Z-
dc.date.available2018-11-24T13:16:27Z-
dc.date.issued2016
dc.identifier.issn1699-258X
dc.identifier.urihttp://hdl.handle.net/10553/50097-
dc.description.abstractObjective:To analyze compliance with t2t clinical practice guidelines.Methods:Cross-sectional observational study in consecutive patients with rheumatoid arthritis (RA) in 5 hospitals in the Canary Islands. Patients filled out activity scales, HAQ and answered the question of whether the doctor had explained the treatment target. The rheumatologist also collected: visits in the past year, use of activity indices and HAQ, DAS28 of current visit and date of the next visit. The percentage of compliance to indicators based on the t2t recommendations (R) 1, 3, 5-7 and 10 was analyzed.Results:A total of 343 patients were recruited, 77% female, mean age 57, RA duration of 10 years. Median visits in the last year were 3 and mean time between last and current visit was 5.6 months. A total of 93% of the patients were treated with DMARDs and 44% were in remission by DAS (R1). In the previous visit, documented joint count was present in 85%, a HAQ in 19%, patient VAS in 41%, and a DAS28 in 35% of the patients (R6). The next visit was scheduled at an average of 4.3 months (R5). In 64% of patients with DAS28> 3.2 a visit between one and 3 months was scheduled (R5). A total of 96% of patients said they had been informed of the treatment target (R10). Variability between centers existed but was moderate. The only factor determining the performance of a DAS28 in the last visit was the patient's center of origin.Conclusion:The Canary Island centers studied achieved high levels of remission and low activity in their patients. The performance of composite indices and follow-up frequency recommended by the t2t are met, although there is room for improvement. (C) 2014 Elsevier Espana, S.L.U.y Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
dc.publisher1699-258X
dc.relation.ispartofReumatologia Clinica
dc.sourceReumatologia Clinica[ISSN 1699-258X],v. 12, p. 34-38
dc.subject.otherRemission Induction Cohort
dc.subject.otherRecommendations
dc.subject.otherStrategy
dc.titleAdjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan study
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1016/j.reuma.2015.03.003
dc.identifier.scopus84954388945
dc.identifier.isi000399027300007
dc.contributor.authorscopusid7003297397
dc.contributor.authorscopusid56189466100
dc.contributor.authorscopusid6603328312
dc.contributor.authorscopusid6603342951
dc.contributor.authorscopusid8654250900
dc.contributor.authorscopusid57198031414
dc.contributor.authorscopusid36469248100
dc.contributor.authorscopusid36543104200
dc.contributor.authorscopusid56582939700
dc.contributor.authorscopusid54412193400
dc.contributor.authorscopusid7003918641
dc.contributor.authorscopusid56583492900
dc.contributor.authorscopusid56584057000
dc.contributor.authorscopusid6603136298
dc.description.lastpage38
dc.description.firstpage34
dc.relation.volume12
dc.type2Artículoes
dc.contributor.daisngid34966644
dc.contributor.daisngid5636869
dc.contributor.daisngid550893
dc.contributor.daisngid1113798
dc.contributor.daisngid343824
dc.contributor.daisngid3734413
dc.contributor.daisngid7192408
dc.contributor.daisngid7105076
dc.contributor.daisngid1345339
dc.contributor.daisngid838281
dc.contributor.daisngid27082302
dc.contributor.daisngid6136907
dc.contributor.daisngid1048977
dc.contributor.wosstandardWOS:Naranjo, A
dc.contributor.wosstandardWOS:Caceres, L
dc.contributor.wosstandardWOS:Hernandez-Beriain, JA
dc.contributor.wosstandardWOS:Francisco, F
dc.contributor.wosstandardWOS:Ojeda, S
dc.contributor.wosstandardWOS:Talaverano, S
dc.contributor.wosstandardWOS:Novoa-Medina, J
dc.contributor.wosstandardWOS:Martin, JA
dc.contributor.wosstandardWOS:Delgado, E
dc.contributor.wosstandardWOS:Trujillo, E
dc.contributor.wosstandardWOS:Alvarez, F
dc.contributor.wosstandardWOS:Magdalena, L
dc.contributor.wosstandardWOS:Rodriguez-Lozano, C
dc.date.coverdateEnero 2016
dc.identifier.ulpgces
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGrupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
crisitem.author.fullNameHernández Beriain, José Ángel-
Appears in Collections:Artículos
Show simple item record

Page view(s)

7
checked on Jun 13, 2021

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.